HAE close: $85 on 2023-08-21 to $108 on 2026-08-19.
Split-adj closes · 240 of 5,309 · price returnⓘ
At a glance
Short interest6.4% of sh out
Days to cover4.6d
13F net flow (QoQ)−9.38%
Top-10 13F concentration51.0%
Next report (est.)2026-11-05
SI 2026-07-31 · 13F 2026-Q1ⓘ
Key fundamentalsFY 2026
P/E (FY)51.0×
Sales (TTM)$1.35B
Earnings (TTM)$96.3M
ROE12.0%
Net margin7.3%
ROIC6.8%
Debt / equity1.54×
Total debt / EBITDA4.56×
EPS growth 3Y−2.9%
Sales growth 3Y4.5%
FY ratios · TTM sales/earnings (USD)ⓘ
Trailing returns
YTD+35.3%
1Y+99.7%
3Y+26.9%
5Y+87.9%
10Y+200.4%
Since incept. (ann.)+8.4%
Total return · from 2005-07-08ⓘ
Risk
Ann. volatility (1Y)50.1%
Ann. volatility (3Y)42.1%
Sharpe (1Y)1.67
Sharpe (3Y)0.40
Max drawdown (1Y)−40.1%
Max drawdown (3Y)−51.0%
Beta (3Y vs SPY)0.51
Daily returns, ann.ⓘ
Top institutional holders13F 2026-Q1
Manager
Shares
Value
% sh out
QoQ
BlackRock, Inc.
5.6M
$317M
12.09%
−3.5%
NEUBERGER BERMAN GROUP LLC
3.6M
$201M
7.66%
−7.9%
AQR CAPITAL MANAGEMENT LLC
3.4M
$186M
7.22%
+6.1%
VANGUARD PORTFOLIO MANAGEMENT LLC
2.6M
$144M
5.51%
new
VANGUARD CAPITAL MANAGEMENT LLC
2.1M
$118M
4.50%
new
STATE STREET CORP
1.8M
$100M
3.82%
+2.5%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
1.4M
$78M
2.98%
+0.2%
River Road Asset Management, LLC
1.3M
$75M
2.86%
+20.5%
Δ vs 2025-Q4 · Institutional 13F holdings sum to 102.5% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 2,583,187 shares (settlement 2026-05-15) accounts for the excess.ⓘ
Latest reported quarterslast report 2026-08-06
Period end
Reported
EPS
EPS YoY
Revenue
Rev YoY
2026-06-27
2026-08-06
$0.72
+2.9%
$339.4M
+5.6%
2026-03-28
2026-05-07
—
—
$346.4M
+4.8%
2025-12-27
2026-02-05
$0.95
+28.4%
$339.0M
−2.7%
2025-09-27
2025-11-06
$0.81
+22.7%
$327.3M
−5.3%
As-reported XBRL · next 2026-11-05 est.ⓘ
Segment mixFY2026 (ended Mar 2026)
Hospital 44% · Plasma 39% · Blood Center 17%
business · TAGGED revenueⓘ
Basis & disclosures
EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
